Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

28.86

+0.54 (1.91%)

At close: Dec 5, 2025, 4:00 PM EST

28.31

-0.55 (-1.91%)

After-hours: Dec 5, 2025, 6:59 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Molecular Profiling Services	349.12M	Log In
Molecular Profiling Services Growth	25.24%	Log In
Pharma Research and Development Services	63.15M	Log In
Pharma Research and Development Services Growth	130.62%	Log In

Revenue by Geography

Fiscal year is January - December.